AI assistant
Sending…
EyePoint Pharmaceuticals, Inc. — Director's Dealing 2018
Mar 30, 2018
32254_dirs_2018-03-30_08664850-9d11-41cc-8fa7-07c974b01349.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: pSivida Corp. (PSDV)
CIK: 0001314102
Period of Report: 2018-03-28
Reporting Person: Eastman Ronald W (Director, 10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 8606324 | Indirect |
Footnotes
F1: The shares are held by EW Healthcare Partners L.P. ("EWHP") and EW Healthcare Partners-A L.P. ("EWHP-A"). The reporting person is a manager of the entity that is the general partner of the general partner of EWHP and EWHP-A, which own the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
More from EyePoint Pharmaceuticals, Inc.
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 13
Director's Dealing
2026
Mar 24
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 4
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 18
Major Shareholding Notification
2026
Feb 12
Director's Dealing
2026
Jan 7